356 related articles for article (PubMed ID: 15716361)
21. Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.
Dauer W; Kholodilov N; Vila M; Trillat AC; Goodchild R; Larsen KE; Staal R; Tieu K; Schmitz Y; Yuan CA; Rocha M; Jackson-Lewis V; Hersch S; Sulzer D; Przedborski S; Burke R; Hen R
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14524-9. PubMed ID: 12376616
[TBL] [Abstract][Full Text] [Related]
22. Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.
Kumar V; Singh D; Singh BK; Singh S; Mittra N; Jha RR; Patel DK; Singh C
Mol Cell Biochem; 2018 Jul; 444(1-2):149-160. PubMed ID: 29198021
[TBL] [Abstract][Full Text] [Related]
23. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
[TBL] [Abstract][Full Text] [Related]
24. Vulnerability of peripheral catecholaminergic neurons to MPTP is not regulated by alpha-synuclein.
Cano-Jaimez M; Pérez-Sánchez F; Milán M; Buendía P; Ambrosio S; Fariñas I
Neurobiol Dis; 2010 Apr; 38(1):92-103. PubMed ID: 20079841
[TBL] [Abstract][Full Text] [Related]
25. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
27. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.
Vivacqua G; Biagioni F; Yu S; Casini A; Bucci D; D'Este L; Fornai F
J Chem Neuroanat; 2012 Jul; 44(2):76-85. PubMed ID: 22580273
[TBL] [Abstract][Full Text] [Related]
28. Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease.
Duperrier S; Bortolozzi A; Sgambato V
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955716
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
[TBL] [Abstract][Full Text] [Related]
30. [Genetics and environmental factors of Parkinson disease].
Broussolle E; Thobois S
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
[TBL] [Abstract][Full Text] [Related]
31. Role of melatonin in TLR4-mediated inflammatory pathway in the MTPT-induced mouse model.
Yildirim S; Ozkan A; Aytac G; Agar A; Tanriover G
Neurotoxicology; 2022 Jan; 88():168-177. PubMed ID: 34808223
[TBL] [Abstract][Full Text] [Related]
32. β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins.
Ninkina N; Millership SJ; Peters OM; Connor-Robson N; Chaprov K; Kopylov AT; Montoya A; Kramer H; Withers DJ; Buchman VL
J Biol Chem; 2021 Dec; 297(6):101375. PubMed ID: 34736896
[TBL] [Abstract][Full Text] [Related]
33. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
Anandhan A; Tamilselvam K; Radhiga T; Rao S; Essa MM; Manivasagam T
Brain Res; 2012 Jan; 1433():104-13. PubMed ID: 22138428
[TBL] [Abstract][Full Text] [Related]
34. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice.
Rojo AI; Montero C; Salazar M; Close RM; Fernández-Ruiz J; Sánchez-González MA; de Sagarra MR; Jackson-Lewis V; Cavada C; Cuadrado A
Eur J Neurosci; 2006 Oct; 24(7):1874-84. PubMed ID: 17067291
[TBL] [Abstract][Full Text] [Related]
35. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
36. Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death.
Sun F; Anantharam V; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
J Pharmacol Exp Ther; 2005 Oct; 315(1):69-79. PubMed ID: 15987830
[TBL] [Abstract][Full Text] [Related]
37. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
Schmidt N; Ferger B
Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
[TBL] [Abstract][Full Text] [Related]
39. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.
Kim HG; Park G; Piao Y; Kang MS; Pak YK; Hong SP; Oh MS
Food Chem Toxicol; 2014 Mar; 65():293-300. PubMed ID: 24389454
[TBL] [Abstract][Full Text] [Related]
40. Striatal 19S Rpt6 deficit is related to alpha-synuclein accumulation in MPTP-treated mice.
Liu B; Shi Q; Ma S; Feng N; Li J; Wang L; Wang X
Biochem Biophys Res Commun; 2008 Nov; 376(2):277-82. PubMed ID: 18782562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]